Back to Trades
Whalen Matthew Pratt
DirectorCIK 0002033867
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 3
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 2
- Active
- 2026
Whalen Matthew Pratt, Director, has filed 3 SEC reports (2026), spread across 2 companies, totaling $158.0K in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
3 loaded
| Jul 27 | TELO Telomir Pharmaceuticals, Inc. | Whalen Matthew Pratt | Director | Award | $0 |
| Jun 15 | MIRA MIRA PHARMACEUTICALS, INC. | Whalen Matthew Pratt | Director | Award | $0 |
| May 22 | TELO Telomir Pharmaceuticals, Inc. | Whalen Matthew Pratt | Director | Award | $158.0K |
3 filings